Stroke prevention in atrial fibrillation with chronic kidney disease: a delicate balance of efficacy and safety considerations

被引：0
|
作者：
Barnes, Geoffrey D. [1 ]
Nunes, Julie A. Wright [2 ]
机构：
[1] Univ Michigan, Frankel Cardiovasc Ctr, Dept Internal Med, Div Cardiovasc Med, 2800 Plymouth Rd B14 G214, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA
来源：
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS | 2024年 / 8卷 / 02期
关键词：
HEMODIALYSIS; APIXABAN;
D O I：
10.1016/j.rpth.2024.102370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
    Bhatia, Harpreet S.
    Bailey, Joseph
    Unlu, Ozan
    Hoffman, Katherine
    Kim, Robert J.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2019, 42 (11): : 1463 - 1470
  • [12] Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Bhatia, Harpreet S.
    Bailey, Joseph
    Unlu, Ozan
    Kim, Robert J.
    CIRCULATION, 2018, 138
  • [13] Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation
    Liu, Chaofan
    Han, Shaojie
    Cui, Kaijun
    Wang, Fang
    PLOS ONE, 2023, 18 (10):
  • [14] Stroke prevention in patients with atrial fibrillation and chronic kidney disease in stage 4 or stage 5
    Petricciuolo, Serena
    Aimo, Alberto
    De Caterina, Raffaele
    GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (01) : 6 - 15
  • [15] Prevention of stroke in patients with atrial fibrillation and chronic kidney disease: difficult choices and clinical decisions
    Gorczyca-Michta, Iwona
    Kluk, Maciej
    Wozakowska-Kaplon, Beata
    KARDIOLOGIA POLSKA, 2012, 70 (09) : 948 - 952
  • [16] Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope
    Hohnloser, Stefan H.
    Connolly, Stuart J.
    EUROPEAN HEART JOURNAL, 2011, 32 (19) : 2347 - 2349
  • [17] Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease
    Ballegaard, Ellen Linnea Freese
    Olesen, Jonas Bjerring
    Kamper, Anne-Lise
    Feldt-Rasmussen, Bo
    Gislason, Gunnar
    Torp-Pedersen, Christian
    Carlson, Nicholas
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (02)
  • [18] The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Mace-Brickman, Trevor
    Eddeen, Anan Bader
    Carrero, Juan-Jesus
    Mark, Patrick B.
    Molnar, Amber O.
    Lam, Ngan N.
    Zimmerman, Deborah
    Harel, Ziv
    Sood, Manish M.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2019, 6
  • [19] COMPARATIVE EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE
    Gorbatenko, V. S.
    Gerasimenko, A. S.
    Shatalova, O., V
    KARDIOLOGIYA, 2020, 60 (09) : 102 - 109
  • [20] Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety
    Salim, Imtiaz
    Al Suwaidi, Jassim
    Ghadban, Wissam
    Salam, Amar M.
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (01) : 53 - 63
12345